Instant NanoBiosensors Co., Ltd. is an innovation-driven biotechnology company specializing in advanced diagnostic platforms. The company operates two major business divisions: Protein Detection Solutions and Genetic Testing Systems. #Protein Detection Solutions – Light Sensing Biomarker Analyzer Our proprietary Light Sensing Biomarker Analyzer integrates Fiber Optic Particle Plasmon Resonance (FOPPR) technology with a microfluidic auto-flow system to deliver ultra-sensitive, label-free biomarker detection. This versatile platform supports: 1.Antibody analysis – including rapid antibody selection and epitope mapping. 2.Low-abundance biomarker detection – enabling precise measurement of trace-level proteins in minimal sample volumes. 3.Support for therapeutic antibody development – facilitating faster and more reliable candidate screening for pharmaceutical pipelines. 4.Early detection of Alzheimer’s disease – offering a blood-based, ultrasensitive assay that enables earlier intervention. The Light Sensing Biomarker Analyzer delivers real-time, reproducible results with minimal sample preparation, making it suitable for research, clinical, and pharmaceutical development environments. #Genetic Testing Systems – INLab NGS Solution Our INLab NGS Solution is a fully automated, end-to-end next-generation sequencing (NGS) system designed to optimize precision medicine workflows. The platform integrates: 1.Automated nucleic acid extraction – ensuring high-quality DNA/RNA isolation with minimal manual handling. 2.Automated library preparation – streamlining a traditionally labor-intensive process. 3.Automated bioinformatics and report generation – delivering clinical-grade reports in significantly less time. Key advantages include: *Labor savings – reducing the need for highly specialized manpower. *Lower error rates – minimizing variability from manual steps. *Cost reduction – enabling more affordable access to advanced genetic testing. The INLab NGS Solution supports a broad range of oncology applications, including solid tumors and hematologic malignancies such as leukemia. It is already in use at leading international medical centers, demonstrating its reliability, scalability, and clinical impact. Our Commitment: Instant NanoBiosensors is dedicated to bridging scientific innovation with clinical practicality. By providing accurate, efficient, and accessible diagnostic solutions, we aim to empower healthcare providers, advance biomedical research, and improve patient outcomes on a global scale.